TrialStem cell research & therapy2025

Outcomes of autologous bone marrow mononuclear cell administration combined with educational intervention in the treatment of autism spectrum disorder: a randomized, open-label, controlled phase II clinical trial.

Liem Thanh Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.